Hayri Demirbaş
- Co-authors
- Syed Rizwan Ali ShahKui ZhuSyeda Tasmia AsmaSyed Zajif HussainDmitry MorozovDamla Arslan‐AcarözViorel HermanAbdelhanine Ayad
- Topics
- Peripheral Neuropathies and Disorders (4 papers)Botulinum Toxin and Related Neurological Disorders (3 papers)Infectious Encephalopathies and Encephalitis (3 papers)
- Cited by
- Drug DiscoveryToxicologyBiochemistry
- Journals
- SHILAP Revista de lepidopterologíaCancersParkinsonism & Related Disorders
In The Last Decade
Hayri Demirbaş
20 papers receiving 254 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 81
- Neurology 34
- Pathology and Forensic Medicine 30
- Plant Science 30
- Epidemiology 28
Countries citing papers authored by Hayri Demirbaş
This map shows the geographic impact of Hayri Demirbaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayri Demirbaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayri Demirbaş more than expected).
Fields of papers citing papers by Hayri Demirbaş
This network shows the impact of papers produced by Hayri Demirbaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayri Demirbaş. The network helps show where Hayri Demirbaş may publish in the future.
Co-authorship network of co-authors of Hayri Demirbaş
This figure shows the co-authorship network connecting the top 25 collaborators of Hayri Demirbaş. A scholar is included among the top collaborators of Hayri Demirbaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayri Demirbaş. Hayri Demirbaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Natural Products/Bioactive Compounds as a Source of Anticancer Drugsbreakdown → | 160 |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 19 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 7 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 18 | |
| 12 | 3 | |
| 13 | 2 | |
| 14 | 2 | |
| 15 | 15 | |
| 16 | Akut iskemik inmeli olgularda Kocatepe Üniversitesi Nöroloji Kliniği’nin İntravenöz trombolitik tedavi deneyimleri | 1 |
| 17 | 2 | |
| 18 | 11 | |
| 19 | 1 | |
| 20 | 2 |
About Hayri Demirbaş
Hayri Demirbaş is a scholar working on Neurology, Neurology and Internal Medicine, having authored 22 papers that have together received 261 indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Infectious Encephalopathies and Encephalitis (3 papers). The work is most often cited by research in Drug Discovery (1 citation), Toxicology (13 citations) and Biochemistry (14 citations). Hayri Demirbaş has collaborated with scholars based in Türkiye, China and Romania. Frequent co-authors include Syed Rizwan Ali Shah, Kui Zhu, Syeda Tasmia Asma, Syed Zajif Hussain, Dmitry Morozov, Damla Arslan‐Acaröz, Viorel Herman, Abdelhanine Ayad, Zehra Hajrulai-Musliu and Fatih Ramazan İstanbullugil. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancers and Parkinsonism & Related Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.